HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emergency contraception: clinical outcomes.

Abstract
Emergency contraception (EC) is widely used to prevent unwanted pregnancy. This review considers the safety and efficacy of three commonly used methods -- levonorgestrel (LNG-EC), ulipristal acetate (UPA) and the copper intrauterine device. All are extremely safe, and side effects are minimal. Concerns about increased risks of ectopic pregnancy after EC use have proved unfounded, and possible teratogenic effects seem unlikely. Although the true effectiveness of EC is impossible to estimate, recent research suggests that LNG-EC prevents around 50% of expected pregnancies in women using the method within 72 h of intercourse, whereas UPA appeared to prevent almost two thirds of pregnancies. Emergency intrauterine device insertion probably prevents over 95% of pregnancies. However, although improved accessibility of EC has clearly led to increased use, it does not appear to have had any public health benefit in reducing unintended pregnancy rates. Most of the data on sexual behavior following improved access to EC do not show any detrimental effect on subsequent use of other more effective methods of contraception or on the incidence of unintended pregnancy or sexually transmitted infection. However, unless these other methods of contraception are also made easily available from pharmacies, improved access to EC risks unlinking its use with use of subsequent ongoing contraception.
AuthorsAnna Glasier
JournalContraception (Contraception) Vol. 87 Issue 3 Pg. 309-13 (Mar 2013) ISSN: 1879-0518 [Electronic] United States
PMID23040128 (Publication Type: Comparative Study, Journal Article, Review)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Contraceptive Agents, Female
  • Norpregnadienes
  • Levonorgestrel
  • ulipristal acetate
Topics
  • Contraception Behavior
  • Contraception, Postcoital (methods)
  • Contraceptive Agents, Female (administration & dosage, adverse effects)
  • Female
  • Humans
  • Intrauterine Devices, Copper (adverse effects)
  • Levonorgestrel (administration & dosage, adverse effects)
  • Norpregnadienes (administration & dosage, adverse effects)
  • Pregnancy
  • Pregnancy Rate
  • Risk-Taking
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: